Skip to the main content
Open WellbeingWhat the studies actually measured

Blood sugar and insulin

Chromiumand Fasting plasma glucose

Only one source here so far, and it measured lower fasting plasma glucose.

How sure anyone can be

Very low certainty, level 1 of 4

Any estimate here is very uncertain.

The numbers reported

One source’s range, drawn against its own line of no difference and scaled to its own numbers.

-36.15-19 mg/dL-1.85

This range stays on one side of the no-difference line.

Bar the confidence interval — the range the true effect is likely to sit inNotch the number the source reportedLine where there would be no difference at all

One source, newest first

What we read is the published abstract, not the full paper, so a blank below may still be printed in the paper itself. A fixed rule worked this out from the source’s own fields. Nobody checked this rating by hand.

  • Systematic review, 2020 · 28 studies pooled

    Very low certainty, level 1 of 4

    Effects of chromium supplementation on glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.

    Pharmacol Res. 2020;161:105098. doi:10.1016/j.phrs.2020.105098. PMID:32730903.

    Number reported
    -19 mg/dL
    Which way it went
    Lower
    Likely range
    -36.15 to -1.85
    Source’s own words
    mg/dl fasting plasma glucose, weighted mean difference vs control
    Who was studied
    Adult with type 2 diabetes
    Compared with
    placebo or control
    Amount taken
    Recorded detail — mcg/d elemental chromium
    For how long
    Not in the abstract
    Disagreement between studies
    I2 = 99.8%
    Kind of record
    Journal article
    How this rating was reachedstarts at High, 3 steps down: risk of bias, imprecision and inconsistency
    1. Starts at High
    2. Risk of bias brought it down to Moderatethe abstract reports no risk-of-bias or quality appraisal, so study limitations cannot be ruled outNot in the abstract
    3. Imprecision brought it down to Lowthe abstract does not state how many participants were pooledNot in the abstract
    4. Inconsistency brought it down to Very lowheterogeneity across pooled studies is high (I² = 99.8%)Reported in the abstract
    5. Ends at Very low3 steps down.
    Checked, nothing to step it down for
    indirectness

    Imprecision stops at the first check that applies; others may apply too.

    AI review could not confirm it — an AI agent re-read this finding against the saved source and at least one check failed. The batch record names the check and quotes the sentence that caused the doubt. No person read it.

    Read the abstract on PubMed

What is still missing from these readings

  • One do not say how many people took part.
  • For how long — Not in the abstract.

Something nobody wrote down is never a zero and never a guess.

Still to read for Chromium

Two of the 11 things on our list for Chromium have no reading here yet:

  • Blood glucose (continuous, CGM)
  • Body fat percentage

Still to read means nobody here has got to it, not that it was tried and did nothing or that no research exists. A pairing on no list is not a gap: we never set out to read it.

Read next

This is a library, not advice. No recommendation, no dose, no diagnosis, no ranking. We never ask about your symptoms, and nothing here is tailored to you.